METLIFE INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $MET in the last 30 days.
See all $MET insider activity →MetLife (MET) returned $2.4B to shareholders, Allstate (ALL) reported a 86.6 combined ratio, and Travelers (TRV) raised dividends for 22 years. Rising rates boost insurers' profits via investment income. MET, ALL, and TRV show strong financials and dividend growth.
MetLife's CFO, John D. McCallion, sold 6,057 shares on Aug. 31, 2026, to cover tax liabilities from restricted stock units. He still holds 269,137 shares worth $25.4M. MetLife's stock has returned 17% in one year, with strong revenue growth but declining net income and margins.
MetLife (MET) has outperformed the Nasdaq Composite, with shares up 22.5% year-to-date and 32.6% over 52 weeks. The company reported a 15.5% increase in adjusted earnings and 7% revenue growth in Q2 2026. Analysts have a 'Moderate Buy' rating with a mean price target of $106.23.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning MET (METLIFE INC). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent MET coverage spans sector analysis, financial news and earnings.
Higher rates boost MetLife's investment income, enhancing dividend capacity.
Minor dilution of insider ownership; no immediate price impact expected.
Strong earnings beat and guidance lift support upside.
The fresh capital boost may improve MetLife's earnings outlook and support its reinsurance growth.
Potential revenue uplift from new super fund mandates could boost MetLife's earnings outlook.
AlphAI scores every news story that mentions MET with an AI model for sentiment and relevance, and aggregates insider trades from METLIFE INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
MetLife (MET) returned $2.4B to shareholders, Allstate (ALL) reported a 86.6 combined ratio, and Travelers (TRV) raised dividends for 22 years. Rising rates boost insurers' profits via investment income. MET, ALL, and TRV show strong financials and dividend growth.
3 min readMetLife's CFO, John D. McCallion, sold 6,057 shares on Aug. 31, 2026, to cover tax liabilities from restricted stock units. He still holds 269,137 shares worth $25.4M. MetLife's stock has returned 17% in one year, with strong revenue growth but declining net income and margins.
2 min readMetLife (MET) has outperformed the Nasdaq Composite, with shares up 22.5% year-to-date and 32.6% over 52 weeks. The company reported a 15.5% increase in adjusted earnings and 7% revenue growth in Q2 2026. Analysts have a 'Moderate Buy' rating with a mean price target of $106.23.
2 min readChariot Re, a reinsurance sidecar by MetLife (MET) and General Atlantic, raised $700M in equity and debt. The capital will expand its life and annuity reinsurance platform. Chariot Re has raised over $2B since its 2025 launch, reinsuring $20B in liabilities. MetLife and General Atlantic cited strong business momentum and investor confidence.
2 min readAPRA raised concerns about smaller super funds with high administration costs, noting 17 products had significantly high fees, 13 of which were from funds with less than $10 billion in assets. The regulator suggested underperforming funds consider consolidation. Group risk market is dominated by TAL, AIA Australia, and MetLife, with recent mandate shifts impacting market positions. KPMG data showed group lump-sum risk had a negative insurance service result in FY2025, with rising claims-to-premi
3 min readMetLife (MET) filed a notice under Rule 144 for a proposed sale of 15,400 shares of common stock by a Separate Account, with Barclays as broker, expected on or around 08/28/2026. The company had 635,476,927 shares outstanding at the time of filing. Recent sales under Rule 144 included 128 shares on 05/28/2026 and 332 shares on 06/18/2026.
1 min readSanDisk (SNDK), Phillips 66 (PSX), and MetLife (MET) collectively authorized $27B in share buybacks. SanDisk, up 500% in 2026, added $14B, while Phillips 66 and MetLife authorized $10B and $3B, respectively. Each company cited strong cash generation and confidence in future earnings.
2 min readMetLife settled a class-action lawsuit for $23 million, resolving claims that it underpaid retirees by using outdated actuarial tables. The case, McAlister et al. v. MetLife, alleged violations of ERISA. The settlement covers retirees who received benefits under various MetLife plans since 2013. MetLife's Retirement Plan had over 13,200 members and $7.9 billion in assets as of 2024.
2 min readMetLife (MET) and Realty Income (O) show divergent reactions to 30-year Treasury yields at 5.31%. MET benefits from higher yields, with Q1 2026 net investment income up 10% and dividends raised twice. O faces yield competition, though fundamentals remain solid. Other dividend stocks like ARCC, VNO, and VZ are also impacted by debt structures and refinancing costs.
3 min readMetLife (MET) Q2 2026 earnings call reported adjusted earnings of about $1.6 billion, or $2.43 per share, up 15% year over year. Adjusted premiums, fees and other revenues rose 5% (excluding pension risk transfers). Sales increased 7%, led by international growth. MetLife repurchased about $700 million of shares in the quarter and announced a new $3 billion authorization.
7 min read
